BioLoomics innovates at the intersection of synthetic biology, machine learning, and protein design to enhance antibody-drug conjugate internalization and trafficking.
Our team of interdisciplinary pioneers is dedicated to creating advanced therapeutic solutions for patients with unmet medical needs, pushing the boundaries to develop the next generation of antibody scaffolds.